Australia markets closed

Imricor Medical Systems, Inc. (IMR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.5100+0.0150 (+3.03%)
At close: 03:34PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
615.568
615.568
816.011
696.267
702.161
-
Cost of revenue
1,731
1,731
2,343
2,592
1,100
-
Gross profit
-1,116
-1,116
-1,527
-1,896
-397.672
-
Operating expenses
Research development
7,920
7,920
7,946
9,675
5,546
-
Selling general and administrative
7,820
7,820
7,787
8,688
6,012
-
Total operating expenses
16,460
16,460
16,468
19,148
12,107
-
Operating income or loss
-17,575
-17,575
-17,995
-21,044
-12,505
-
Interest expense
47.947
47.947
177.917
108.849
300.637
-
Total other income/expenses net
-5,773
-5,773
-3.755
714.724
-198.398
-
Income before tax
-22,626
-22,626
-17,356
-19,733
-12,446
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-22,626
-22,626
-17,356
-19,733
-12,446
-
Net income
-22,626
-22,626
-17,356
-19,733
-12,446
-
Net income available to common shareholders
-22,626
-22,626
-17,356
-19,733
-12,446
-
Basic EPS
-0.11
-
-0.12
-0.15
-0.11
-0.21
Diluted EPS
-0.11
-
-0.12
-0.15
-0.11
-0.21
Basic average shares
149,795
-
150,495
135,065
113,728
62,499
Diluted average shares
149,795
-
150,495
135,065
113,728
62,499